Fisetin proved to be an effective inhibitor of melanoma cell invasion by promoting mesenchymal to epithelial transition and targeting MAPK, and NF-κb signaling pathways in three-dimensionally reconstituted human melanoma skin equivalents [109]. The gene discussed is NFKB1; the disease is melanoma.